A month has gone by since the last earnings report for Hologic, Inc. HOLX. Shares have added about 3.5% in that time frame, outperforming the market. Will the recent positive trend continue leading up to the stock's next earnings release, …
Yahoo!10mon
Although Carl Icahn still owns more than 25 million shares of HOLX, the sale and the resignation of the two ... but also lowered their target prices on the stock. FBN Securities, for instance, lowered its target on Ambarella from $70 to $60, …
Stock-Callers.com has lined up four equities in the Medical Appliances and Equipment industry: Abbott Laboratories …
Sometimes when I analyze a stock, I am reminded of the marvels that investment bankers can do for their valuations, especially if the company is a good client. With its recent $3.7 billion acquisition of Gen-Probe, I would bet that Hologic …
Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Hologic Inc.’s control of the market for 3D breast imaging in cancer screening is based on misuse of its patents …
Hologic, Inc. HOLX has an Earnings ESP of +0.94% and a Zacks Rank #3 ... But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%. And this …
Imagin Medical Inc. (OTC: IMEXF), Endocyte, Inc. (NASDAQ: ECYT), Hologic, Inc. (NASDAQ: HOLX), Boston Scientific Corporation ... in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the …
Shares of HOLX soared in July when the company named Jack Cumming its President and Chief Executive Officer. Mr. Cumming joined Hologic in 2001 and served as Chief Executive Officer from 2001 to 2009. However, the stock was …
We are in the middle of the third-quarter earnings season with 291 S&P 500 members (58.2% of the total index) having released their quarterly numbers, as of Oct 28. After five consecutive quarters of earnings declines for the S&P 500 …